首页 › 期刊 › 医学 › Coronary Artery Disease
Coronary Artery Disease
出版商:Ovid Technologies (Wolters Kluwer) - Lippincott Williams & Wilkins · ISSN:0954-6928, 1473-5830 · 国家/地区:GB · 类型:journal · 官网:https://journals.lww.com/coronary-artery/pages/default.aspx
研究主题:Coronary Interventions and Diagnostics · Cardiac Imaging and Diagnostics · Acute Myocardial Infarction Research · Cardiovascular Function and Risk Factors · Coronary Artery Anomalies
数据覆盖:9 个公开学术数据源交叉核验(crossref、fqb、jcr、openalex、scimago、wikidata、xr、cwts、jufo)。
数据来源与实体核验
期刊官网 · OpenAlex 期刊实体 · Wikidata 期刊实体
核心指标
- 影响因子(JCR 2025):2.200
- JCR 分区:Q3(CARDIAC & CARDIOVASCULAR SYSTEMS)
- 中科院分区(2025):医学 4区,大类排名 3793/5603;小类:CARDIAC & CARDIOVASCULAR SYSTEMS 心脏和心血管系统 4区,排名 161/223
- 新锐分区(2026):医学 4区
- SJR:0.455(Q3),2025 年,United States
- CWTS 2025:SNIP 0.716 · IPP 1.701 · 自引率 3.0%
- JUFO 出版渠道等级:芬兰 1 · 挪威 1 · 丹麦 1
- h-index:79
- i10 指数:1505
- 近两年篇均被引:1.43
- 载文量 4057 · 总被引 53176
- Crossref DOI 总量:3987,近期 349
逐年趋势
- 近年影响因子:2021 1.72 → 2022 1.8 → 2023 1.5 → 2024 2 → 2025 2.2
- 近年 SJR:2021 0.395(Q3) → 2022 0.419(Q3) → 2023 0.384(Q3) → 2024 0.46(Q3) → 2025 0.455(Q3)
同学科期刊推荐
- CA-A CANCER JOURNAL FOR CLINICIANS — IF 685.2 · JCR Q1 · 中科院1区(Top)
- The Lancet — IF 109.0 · JCR Q1 · 中科院1区(Top)
- MMWR Surveillance Summaries — IF 96.9 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Clinical Oncology — IF 94.6 · JCR Q1 · 中科院1区(Top)
- Nature Reviews Drug Discovery — IF 91.2 · JCR Q1 · 中科院1区(Top)
- New England Journal of Medicine — IF 84.5 · JCR Q1 · 中科院1区(Top)
- Signal Transduction and Targeted Therapy — IF 81.2 · JCR Q1 · 中科院1区(Top)
- Annals of Oncology — IF 80.4 · JCR Q1 · 中科院1区(Top)
常见问题
《Coronary Artery Disease》的影响因子是多少?
根据 JCR 2025 年数据,《Coronary Artery Disease》的最新影响因子(IF)为 2.200。
《Coronary Artery Disease》是几区期刊?
《Coronary Artery Disease》中科院分区(2025年版)为医学4区,JCR 分区为 Q3。
本刊近期代表论文
- Uric acid-to-albumin ratio × monocyte-to-lymphocyte ratio is a novel biomarker for predicting all-cause mortality and cardiovascular mortality in patients with ST-segment elevation myocardial infarction (2025 · 被引 2)
- The HALP score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention (2024 · 被引 19)
- Headache as the sole clinical manifestation of acute myocardial infarction: one case with cardiac cephalalgia and literature review (2024 · 被引 2)
- Safety and efficacy of intracoronary prourokinase administration in patients with high thrombus burden (2020 · 被引 22)
- Age shock index and age-modified shock index are strong predictors of outcomes in ST-segment elevation myocardial infarction patients undergoing emergency percutaneous coronary intervention (2019 · 被引 35)
- Interaction between eNOS gene polymorphism and current smoking on susceptibility to coronary heart disease in Chinese people (2019 · 被引 9)